# Kannact
Kannact Inc. is an Oregon-incorporated digital-health startup, founded in 2012 by Krishna Rao and based in [Portland, Oregon](https://www.edgepedia.org/portland-oregon), that provides at-home management of diabetes and other chronic conditions by combining cloud-connected blood glucose monitoring devices, board-certified health coaching, and pharmacy and supply-delivery services.[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) • [2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) The company drew press attention in 2014 and 2016 for its remote-monitoring hardware and its "pharma" model; its own website and a later promotional profile indicate it was still operating, but its status as of 2026 rests mainly on self-reported signals.
| Fact | Detail |
|---|---|
| Founded | Registered in Oregon on August 24, 2012; first securities sale January 19, 2013[3](https://opencorpdata.com/us-or/87816097) • [1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) |
| Founder and CEO | Krishna Rao (registered agent at incorporation, executive officer on SEC filings)[3](https://opencorpdata.com/us-or/87816097) • [1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) |
| Headquarters | 10260 S Greenburg Rd, Suite 525, Portland, OR (early operations in Albany and Corvallis, OR)[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) • [4](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering) |
| Sector | Digital health: diabetes and chronic-condition remote monitoring and coaching[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) |
| Funding (SEC Form D) | $5,966,000 total amount sold per the January 2016 Form D/A; the corrected March 2014 filing reports $1,179,500 sold to 30 total investors[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) |
| Funding (press) | $8.5 million total by January 2016, including $2 million in founder loans[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) |
| Traction (2016) | 20 employees, two corporate clients, about 1,500 users, targeting 10,000 within six months[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) |
| Status | Website live and marketing active programs at last retrieval[5](https://kannact.com/es/providers) |
## History and founding
Kannact was registered with the Oregon Corporation Division on August 24, 2012 as a domestic business corporation, with Krishna Rao as registered agent at an Albany, Oregon address.[3](https://opencorpdata.com/us-or/87816097) Its first SEC Form D filing reported a first sale of securities on January 19, 2013, under the Regulation D 506(b) exemption with a $10,000 minimum investment.[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt)
The company's first product was Gladstone, an Android tablet-based home care and remote patient monitoring system. In 2014 Kannact, then described as [Corvallis, Oregon](https://www.edgepedia.org/corvallis-oregon)-based, raised $3 million in a first round from undisclosed angel investors and was seeking an additional $3 million.[4](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering) By 2016 the company had shifted toward a combined device-plus-pharmacy model for diabetes and had moved its headquarters to Portland.[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) • [1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt)
## Products and services
Kannact's 2016 offering combined a blood glucose monitoring device that automatically logs readings and sends data in real time to the cloud with coaching, an in-house pharmacist, and delivery of supplies such as glucometer test strips; chief executive Krishna Rao described the model as a "pharma."[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/) The earlier Gladstone tablet connected over [Bluetooth](https://www.edgepedia.org/bluetooth) to pulse oximeters, weight scales, and blood pressure monitors, streaming readings back to the primary care office and flagging out-of-range patients to providers.[4](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering)
According to the company's own website, each patient is assigned a board-certified health coach who conducts remote patient monitoring using connected glucometers and blood pressure cuffs, tracks medication adherence through real-time prescription fulfillment data, and works within the electronic health record systems providers already use.[5](https://kannact.com/es/providers) The site lists the clinical metrics the program targets: HbA1c control below 8%, blood pressure control below 140/90, medication adherence (proportion of days covered) above 80%, preventive cancer screenings, and depression and alcohol-use screenings. Kannact states that it takes risk in its value-based-care contracts, meaning it is paid only when outcomes are delivered.[5](https://kannact.com/es/providers)
## Funding
Kannact's documented fundraising was modest for a health-tech startup and relied partly on its founders. In 2014 it raised $3 million in a first round from undisclosed angel investors for the Gladstone system.[4](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering) In January 2016 GeekWire reported the company had closed another $3 million, bringing total funding to $8.5 million, of which $2 million was loans from the founders.[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/)
The SEC record is smaller than the press total. The Form D/A filed January 25, 2016 reports a total amount sold of $5,966,000 with the offering size indefinite, and a correction to the March 7, 2014 filing states $1,179,500 sold to 30 total investors, including one non-accredited investor.[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt) The same filing reports issuer revenue of $1,000,001 to $5,000,000 in the "Other Technology" category. The sources do not settle the difference between the $5.97 million in reported securities sales and the $8.5 million press figure. No Form D activity after January 2016 appears in the record.[1](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt)
## Business, customers and traction
Kannact sold to health insurers and employers rather than directly to consumers. In the Gladstone era it priced the software at about $2 per covered member per month, with pilots at St. Charles Health System and at a coordinated care organization serving children with Type I diabetes.[4](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering) As of January 2016 the company had 20 employees, two corporate clients, and about 1,500 users, with a stated goal of 10,000 users within six months.[2](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/)
A later, undated profile in IndiaPost, based on the company's own account, describes Kannact as a tech-driven wrap-around care clinic that had supported more than 400,000 individuals, including City of Dallas employees, signed with three large health systems, and launched a California-focused subsidiary called Starlight Solutions.[6](https://indiapost.com/kannact-health-is-bridging-the-last-mile-of-effective-health-care-journey/) These figures are self-reported and not independently corroborated.
## Status after 2016
The company's website was live at retrieval, marketing an active coaching and remote-monitoring program, which is a signal of ongoing operation, though the retrieval date is not independently dated.[5](https://kannact.com/es/providers) The IndiaPost profile's mention of the Starlight Solutions subsidiary and large health-system contracts, if accurate, indicates continued growth at some point after 2016.[6](https://indiapost.com/kannact-health-is-bridging-the-last-mile-of-effective-health-care-journey/) Kannact's status as of 2026 is therefore best described as operating per its own signals but unverified by independent reporting.
## References
1. [SEC EDGAR Form D/A — Kannact INC (CIK 0001601644, filed 2016-01-25)](https://www.sec.gov/Archives/edgar/data/1601644/0001601644-16-000004.txt)
2. [Kannact raises more cash for at-home diabetes management platform — GeekWire (Jan 27, 2016)](https://www.geekwire.com/2016/kannact-raises-cash-home-diabetes-management-platform/)
3. [KANNACT, INC. — Oregon Secretary of State registry record (via OpenCorpData)](https://opencorpdata.com/us-or/87816097)
4. [Kannact raises $3M for tablet-based home health offering — MobiHealthNews (2014)](https://www.mobihealthnews.com/news/kannact-raises-3m-tablet-based-home-health-offering)
5. [Kannact — Providers page (company website)](https://kannact.com/es/providers)
6. [Kannact Health Is Bridging The 'Last Mile' Of Effective Health Care Journey — IndiaPost (undated, partly promotional)](https://indiapost.com/kannact-health-is-bridging-the-last-mile-of-effective-health-care-journey/)
---
*Topic: Encyclopedia › Society and history › Economics and business › Business and work › Business and work overview › Companies and corporations › Venture-backed startups and growth companies › Health, biotech, and medtech startups › Digital health and health IT companies › Telehealth and virtual care companies*
*Initially written Sep 17, 2026 · Edited: Oct 11, 2026; Oct 15, 2026*
*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*
License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license